Clinical Oncology
Volume 21, Issue 1 , Pages 32-38 , February 2009

Inter-observer Variability of Prostate Delineation on Cone Beam Computerised Tomography Images

  • E.A. White

      Affiliations

    • The Radiation Medicine Programme, Princess Margaret Hospital, Toronto, Canada
    • ,
  • K.K. Brock

      Affiliations

    • The Radiation Medicine Programme, Princess Margaret Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
    • ,
  • D.A. Jaffray

      Affiliations

    • The Radiation Medicine Programme, Princess Margaret Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
    • ,
  • C.N. Catton

      Affiliations

    • The Radiation Medicine Programme, Princess Margaret Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
    • Corresponding Author InformationAuthor for correspondence: C. N. Catton, Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto ON, M5G 2M9, Canada. Tel: +1-416-946-2121; Fax: +1-416-946-4586.

Received 21 September 2008 ,Revised 8 November 2008 ,Accepted 18 November 2008.

References 

  1. Kuban D, Tucker S, Dong L, et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:67–74
  2. Peeters S, Heemsbergen W, Koper P, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68Gy of radiotherapy with 78Gy. J Clin Oncol. 2006;24:1990–1996
  3. Sathya J, Davis I, Julian J, et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol. 2005;23:1192–1199
  4. Dearnaley D, Sydes M, Graham J, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8(6):475–487
  5. Zietman A, DeSilvio M, Slater J, et al. Comparison of conventional-dose versus high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294:1233–1239
  6. Zietman A. Correction: inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate. JAMA. 2008;299:898–899
  7. Zelefsky M, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 1999;85:2460–2468
  8. Huang E, Pollack A, Levy L, et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;54:1314–1321
  9. Peeters S, Heemsbergen W, van Putten W, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68Gy to 78Gy. Int J Radiat Oncol Biol Phys. 2005;61:1019–1034
  10. Chism D, Horwitz E, Hanlon A, Pinover W, Mitra R, Hanks G. Late morbidity profiles in prostate cancer patients treated to 79–84Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys. 2003;55:71–77
  11. de Crevoisier R, Tucker S, Dong L, et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:965–973
  12. Heemsbergen W, Hoogeman M, Witte M, Peeters S, Incrocci L, Lebesque J. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68Gy vs 78 Gy. Int J Radiat Oncol Biol Phys. 2007;67:1418–1424
  13. Nichol A, Chung P, Lockwood G, et al. A phase II study of localized prostate cancer treated to 75.6Gy with 3D conformal radiotherapy. Radiother Oncol. 2005;76:11–17
  14. Skala M, Rosewall T, Dawson L, et al. Patient-assessed late toxicity rates and principal component analysis following image guided radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007;68:690–698
  15. Langen K, Pouliot J, Anezinos C, et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:635–644
  16. Artignan X, Smitsmans M, Lebesque J, Jaffray D, van Herk M, Bartelink H. Online ultrasound image guidance for radiotherapy of prostate cancer: impact of image acquisition on prostate displacement. Int J Radiat Oncol Biol Phys. 2004;59:595–601
  17. Jaffray D, Siewerdsen J, Wong J, Martinez A. Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53:1337–1349
  18. Moseley D, White E, Wiltshire K, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 2007;67:942–953
  19. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque J. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys. 1999;43:57–66
  20. Song W, Chiu B, Bauman G, et al. Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy. Int J Radiat Oncol Biol Phys. 2006;65:595–607
  21. Feldkamp L, Davis L, Kress J. Practical cone-beam algorithm. J Opt Soc Am. 1984;1:612–619
  22. Brock K, Sharpe M, Dawson L, Kim S, Jaffray D. Accuracy of finite element model-based multi-organ deformable image registration. Med Phys. 2005;32:1647–1659
  23. Valicenti R, Sweet J, Hauck W, et al. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:931–935
  24. Létourneau D, Wong R, Moseley D, et al. Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performance. Int J Radiat Oncol Biol Phys. 2007;67:1229–1237
  25. Court L, Dong L. Automatic registration of the prostate for computed-tomography-guided radiotherapy. Med Phys. 2003;30:2750–2757
  26. Smitsmans M, Wolthaus J, Artignan X, et al. Automatic localization of the prostate for on-line or off-line image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:623–635
  27. Caldwell C, Mah K, Ung Y, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys. 2001;51(4):923–931
  28. Brock K, Dawson L, Sharpe M, Moseley D, Jaffray D. Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue. Int J Radiat Oncol Biol Phys. 2006;64:1245–1254
  29. Nichol A, Brock K, Lockwood G, et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys. 2007;67:48–56
  30. Smitsmans M, Pos F, de Bois J, et al. The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients. Int J Radiat Oncol Biol Phys. 2008;71:1279–1286

PII: S0936-6555(08)00450-0

doi: 10.1016/j.clon.2008.11.007

Clinical Oncology
Volume 21, Issue 1 , Pages 32-38 , February 2009

Article Tools

* Image Usage & Resolution